Keenova Therapeutics plc: all 247 studies

Page 2 of 3. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Opioid-induced Bowel Dysfunction: Pivotal Assessment of LubiprostoneCompletedNCT00595946Phase 3Results posted
• Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the KneeCompletedNCT00589979Phase 2Results posted
• Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic FibrosisCompletedNCT00570349Phase 1/2Results posted
• Nitric Oxide in Myocardial Infarction SizeTerminatedNCT00568061Phase 2Results posted
• Study of the Efficacy and Safety of Intravenous vs Oral Acetaminophen for Treatment of Fever in Healthy Adult MalesCompletedNCT00564629Phase 3Results posted
• Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop PainCompletedNCT00564486Phase 3Results posted
• Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature BabiesCompletedNCT00551642Phase 3Results posted
• Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back PainCompletedNCT00549042Phase 3Results posted
• Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseCompletedNCT00533273Phase 3Results posted
• A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's ContractureCompletedNCT00528931Phase 1Results posted
• Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseCompletedNCT00528840Phase 3Results posted
• AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's ContractureCompletedNCT00528606Phase 3Results posted
• AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseCompletedNCT00528424Phase 3Results posted
• A Study of Fortigel Testosterone Gel 2% in Males With Low TestosteroneCompletedNCT00522431Phase 3Results posted
• Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult MalesCompletedNCT00493311Phase 3Results posted
• Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric InpatientsCompletedNCT00493246Phase 1Results posted
• Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal MenCompletedNCT00467870Phase 3Results posted
• Safety and Efficacy of Lubiprostone in Pediatric Patients With ConstipationCompletedNCT00452335Phase 4Results posted
• Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic SurgeryCompletedNCT00399568Phase 3Results posted
• Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With ConstipationCompletedNCT00399542Phase 3Results posted
• Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With ConstipationCompletedNCT00380250Phase 3Results posted
• Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous CathetersCompletedNCT00231153Phase 3Results posted
• Nitric Oxide Inhalation to Treat Sickle Cell Pain CrisesCompletedNCT00094887Phase 2Results posted
• The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) ImplantationCompletedNCT00060840Phase 2Results posted
• A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)CompletedNCT06169319Phase 2
• Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)CompletedNCT06151197Phase 3
• Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's ContractureTerminatedNCT05877066
• Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's DiseaseTerminatedNCT05873595
• Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar FibromatosisCompletedNCT05254457Phase 3
• Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With LaxityCompletedNCT05249257
• Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced ChildrenSuspendedNCT04681027Phase 3
• Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)TerminatedNCT04680156
• Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)CompletedNCT04381117
• Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot UlcersTerminatedNCT04134143Phase 1
• MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain FunctionWithdrawnNCT04128462Phase 3
• Safety and Pharmacokinetics of Vasopressin in Healthy VolunteersCompletedNCT04093050Phase 1
• Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in WomenCompletedNCT03893890
• OCR002-SP103 - Oral Immediate Release StudyCompletedNCT03846843Phase 1
• Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) DiseaseWithdrawnNCT03687476Phase 2
• Registry to Evaluate INOmax in Newborn Babies With Pulmonary HypertensionTerminatedNCT03132428
• Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy SubjectsCompletedNCT02966860Phase 1
• Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute PainWithdrawnNCT02767349Phase 1
• Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)TerminatedNCT02685189
• Efficacy and Safety of Stannsoporfin in NeonatesCompletedNCT02685137Phase 3
• ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot UlcersCompletedNCT02657876Phase 1
• Observational Registry of Acthar Gel for Participants With Multiple Sclerosis RelapseCompletedNCT02633033
• Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted ConditionsCompletedNCT02561741Phase 1
• Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted ConditionsCompletedNCT02561650Phase 1
• Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and ChemotherapyTerminatedNCT02542215Phase 2
• Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies DiseaseCompletedNCT02298829
• A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic SurgeryCompletedNCT02284256Phase 3
• An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's DiseaseCompletedNCT02267460Phase 3
• Safety and Efficacy Study of Acthar in Subjects With ARDSWithdrawnNCT02113735Phase 2
• Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid TumorsTerminatedNCT02040558Phase 1
• Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)CompletedNCT02033096
• Follow up Study of Patients Having Participated in Clinical Trial 64,185-204CompletedNCT02000830
• Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac SurgeryCompletedNCT01959828Phase 3
• A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry EyeCompletedNCT01843894Phase 1/2
• Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis PigmentosaTerminatedNCT01786395Phase 3
• Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantCompletedNCT01774435Phase 1
• Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 DiseaseCompletedNCT01747135Phase 1
• Safety and Efficacy Study of COV155 for Post-operative Bunionectomy PainCompletedNCT01743625Phase 3
• Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)CompletedNCT01722864Phase 3
• CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture TreatmentCompletedNCT01715467
• Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate CancerCompletedNCT01697384Phase 3
• Emergency Use of OCR-002 in Acute Liver Failure (ALF)No longer availableNCT01634230
• Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid ArthritisApproved for marketingNCT01579890
• Assessing Relapse in Multiple Sclerosis (ARMS) QuestionnaireCompletedNCT01547351
• The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT01518907Phase 1
• Post Approval Commitment StudyCompletedNCT01444729
• Study of Histrelin Subdermal Implant in Patients With Prostate CancerCompletedNCT01394263Phase 3
• A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular DegenerationCompletedNCT01379560Phase 2
• Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG)CompletedNCT01316874Phase 2/3
• A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)TerminatedNCT01314664
• Retrospective Chart Review of ValstarCompletedNCT01304173
• Long-term Safety and Efficacy Study of Octreotide Implant in Patients With AcromegalyTerminatedNCT01295060Phase 3
• Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric SubjectsWithdrawnNCT01206907Phase 3
• Pharmacokinetics, Bioavailability and Safety of PENNSAID® GelCompletedNCT01202799Phase 1
• Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.CompletedNCT01173627Phase 1
• Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) HeadachesCompletedNCT01035983Phase 3
• Vantas Implant Retrieval StudyCompletedNCT01013025
• IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial InfarctionWithdrawnNCT01007461Phase 2
• Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859CompletedNCT00954746
• Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent TumorsTerminatedNCT00944372Phase 4
• Inhaled Nitric Oxide (INO) In Hypoxic Respiratory FailureWithdrawnNCT00922532Phase 3
• Open Label Study of Octreotide Implant in Patients With AcromegalyCompletedNCT00913055Phase 2
• Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic PainCompletedNCT00911287Phase 3
• Oxymorphone Extended Release in Patients With Cancer or Neuropathic PainCompletedNCT00911261Phase 3
• Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the KneeTerminatedNCT00904605Phase 4
• Topical Lidocaine Patch in Low Back PainCompletedNCT00904540Phase 4
• Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back PainCompletedNCT00904475Phase 4
• Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the KneeCompletedNCT00904462Phase 2
• Open Label Assessment of Long-Term Safety and UtilityCompletedNCT00904449Phase 3
• Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back PainTerminatedNCT00904397Phase 4
• Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic EfficacyCompletedNCT00904280Phase 3
• A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain ConditionsCompletedNCT00904202Phase 4
• A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back PainCompletedNCT00904111Phase 2
• Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual MigraineCompletedNCT00904098Phase 4
• Post-operative Efficacy and Safety StudyCompletedNCT00904085Phase 3
• A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back PainCompletedNCT00904020Phase 4

← Keenova Therapeutics plc overview and focus areas